The Metabolic Syndrome in long-term survivors of Haematopoietic Stem Cell Transplantation

Since its introduction more than fifty years ago, haematopoietic stem cell transplantation (HSCT) has transformed from an inescapably fatal procedure to one where cure from malignant and other non-malignant haematological diseases is becoming increasingly common. Nevertheless, longevity is not entirely restored. New causes of mortality have emerged; of particular importance is that of increased cardiovascular disease (CVD), related to metabolic syndrome (MS) and its components. Controversy exists over whether the metabolic abnormalities induced are a direct effect of HSCT itself or a consequence of other therapies involved.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Review Article Source Type: research